Close

Canaccord Adams Reiterates a 'Buy' Rating on BioMimetic Therapeutics (BMTI); Raises PT Oct 14, 2009 11:25AM
Canaccord Adams Maintains a 'Buy' on BioMimetic Therapeutics (BMTI), Drops Price Target Nov 11, 2008 11:07AM